Skip to main content
. 2020 Jun 19;80(10):995–1005. doi: 10.1007/s40265-020-01323-x

Fig. 1.

Fig. 1

Safety and efficacy outcomes in patients receiving/not receiving proton pump inhibitors (PPIs) at baseline: dabigatran 110-mg dual therapy vs warfarin triple therapy. Hazard ratios (HRs) and 95% confidence interval (CIs) from the Cox proportional hazard model; stratified by age (elderly vs nonelderly). CRNMBE clinically relevant non-major bleeding event, DTE death/thromboembolic event, ISTH International Society on Thrombosis and Haemostasis, MBE major bleeding event